Literature DB >> 18231638

Oncogenic Ras-induced morphologic change is through MEK/ERK signaling pathway to downregulate Stat3 at a posttranslational level in NIH3T3 cells.

Hsuan-Heng Yeh1, Chin-Han Wu, Raghavaraju Giri, Ken Kato, Kimitoshi Kohno, Hiroto Izumi, Cheng-Yang Chou, Wu-Chou Su, Hsiao-Sheng Liu.   

Abstract

Ras is a key regulator of the MAP kinase-signaling cascade and may cause morphologic change of Ras-transformed cells. Signal transducer and activator of transcription 3 (Stat3) can be activated by cytokine stimulation. In this study, we unravel that Ha-ras(V12) overexpression can downregulate the expression of Stat3 protein at a posttranslational level in NIH3T3 cells. Furthermore, we demonstrate that Stat3 expression downregulated by Ha-ras(V12) overexpression is through proteosome degradation and not through a mTOR/p70S6K-related signaling pathway. The suppression of Stat3 accompanied by the morphologic change induced by Ha-ras(V12) was through mitogen extracellular kinase (MEK)/extracellular-regulated kinase (ERK) signaling pathway. Microtubule disruption is involved in Ha-ras(V12)-induced morphologic change, which could be reversed by overexpression of Stat3. Taken together, we are the first to demonstrate that Stat3 protein plays a critical role in Ha-ras(V12)-induced morphologic change. Oncogenic Ras-triggered morphologic change is through the activation of MEK/ERK to posttranslationally downregulate Stat3 expression. Our finding may shed light on developing novel therapeutic strategies against Ras-related tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18231638      PMCID: PMC2213899          DOI: 10.1593/neo.07691

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  33 in total

Review 1.  Small GTP-binding proteins.

Authors:  Y Takai; T Sasaki; T Matozaki
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

2.  Plasmid harboring lac repressor and tTA activator genes can regulate two inducible genes in mammalian cells.

Authors:  T Y Chang; Y Y Wen; H H Yeh; S T Wang; I J Su; H S Liu
Journal:  Biotechniques       Date:  1999-09       Impact factor: 1.993

3.  Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells.

Authors:  K Kato; M Nomoto; H Izumi; T Ise; S Nakano; Y Niho; K Kohno
Journal:  Biochim Biophys Acta       Date:  2000-09-07

4.  Osmotic regulation of STAT3 stability in H4IIE rat hepatoma cells.

Authors:  Mohammad Lornejad-Schäfer; Ute Albrecht; Diana Poppek; Thor Gehrmann; Tilman Grune; Johannes G Bode; Dieter Häussinger; Freimut Schliess
Journal:  FEBS Lett       Date:  2005-10-24       Impact factor: 4.124

5.  Stat3 as an oncogene.

Authors:  J F Bromberg; M H Wrzeszczynska; G Devgan; Y Zhao; R G Pestell; C Albanese; J E Darnell
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

6.  Farnesyltransferase inhibitors induce dramatic morphological changes of KNRK cells that are blocked by microtubule interfering agents.

Authors:  N Suzuki; K Del Villar; F Tamanoi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Transformation of mammalian cells by constitutively active MAP kinase kinase.

Authors:  S J Mansour; W T Matten; A S Hermann; J M Candia; S Rong; K Fukasawa; G F Vande Woude; N G Ahn
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

8.  Activated raf induces the hyperphosphorylation of stathmin and the reorganization of the microtubule network.

Authors:  J Lovrić; S Dammeier; A Kieser; H Mischak; W Kolch
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

9.  Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion.

Authors:  H-H Yeh; W-W Lai; H H W Chen; H-S Liu; W-C Su
Journal:  Oncogene       Date:  2006-03-06       Impact factor: 9.867

10.  Selective activation of oncogenic Ha-ras-induced apoptosis in NIH/3T3 cells.

Authors:  H S Liu; C Y Chen; C H Lee; Y I Chou
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more
  13 in total

1.  Ras-related tumorigenesis is suppressed by BNIP3-mediated autophagy through inhibition of cell proliferation.

Authors:  Shan-Ying Wu; Sheng-Hui Lan; Da-En Cheng; Wei-Kai Chen; Cheng-Huang Shen; Ying-Ray Lee; Roberto Zuchini; Hsiao-Sheng Liu
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling.

Authors:  Amy D Paulino; Kiren Ubhi; Edward Rockenstein; Anthony Adame; Leslie Crews; Scott Letendre; Ronald Ellis; Ian P Everall; Igor Grant; Eliezer Masliah
Journal:  J Neurovirol       Date:  2011-06-10       Impact factor: 2.643

3.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

4.  The role of STAT-3 in the induction of apoptosis in pancreatic cancer cells by benzyl isothiocyanate.

Authors:  Ravi P Sahu; Sanjay K Srivastava
Journal:  J Natl Cancer Inst       Date:  2009-01-27       Impact factor: 13.506

5.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

6.  Role of STAT3 in in vitro transformation triggered by TRK oncogenes.

Authors:  Claudia Miranda; Tiziana Fumagalli; Maria Chiara Anania; Maria Grazia Vizioli; Sonia Pagliardini; Marco A Pierotti; Angela Greco
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

7.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

8.  Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo.

Authors:  Angell Shieh; Ashley F Ward; Kegan L Donlan; Emily R Harding-Theobald; Jin Xu; Charles G Mullighan; Chao Zhang; Shann-Ching Chen; Xiaoping Su; James R Downing; Gideon E Bollag; Kevin M Shannon
Journal:  Blood       Date:  2013-05-01       Impact factor: 22.113

9.  Aurora-A overexpression enhances cell-aggregation of Ha-ras transformants through the MEK/ERK signaling pathway.

Authors:  Ya-Shih Tseng; Jenq-Chang Lee; Chi-Ying F Huang; Hsiao-Sheng Liu
Journal:  BMC Cancer       Date:  2009-12-12       Impact factor: 4.430

10.  Upregulation of tissue factor by activated Stat3 contributes to malignant pleural effusion generation via enhancing tumor metastasis and vascular permeability in lung adenocarcinoma.

Authors:  Hsuan-Heng Yeh; Wen-Tsan Chang; Kuang-Chu Lu; Wu-Wei Lai; Hsiao-Sheng Liu; Wu-Chou Su
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.